Because the dissemination is the main cause of treatment failure and a poor prognosis in ovarian cancer patients, the development of ADC or RIT targeting P-cadherin may be optimal treatment to improve the prognosis of ovarian cancer patients. The gene discussed is CDH3; the disease is ovarian carcinoma.